- January 6, 2020
- Category: Healthcare and LifeSciences, Medical Diagnostics
Global Blood Screening Market Size Study, by Technology (NAT, Rapid Test, Western Blot Assay, NGS) by Product & Service (Reagents & Kits, Instruments, Software & Services) by End Use (Blood Banks, Hospitals) by Regional Forecasts 2019-2026
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion) 1.2.1. Blood Screening Market, by Technology, 2017-2026 (USD Billion) 1.2.2. Blood Screening Market, by Product & Service, 2017-2026 (USD Billion) 1.2.3. Blood Screening Market, by End-Use, 2017-2026 (USD Billion) 1.2.4. Blood Screening Market, by Region, 2017-2026 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Blood Screening Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Blood Screening Market Dynamics 3.1. Blood Screening Market Impact Analysis (2018-2026) 3.1.1. Market Drivers 3.1.2. Market Challenges 3.1.3. Market Opportunities Chapter 4. Global Blood Screening Market Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Blood Screening Market, by Technology 5.1. Market Snapshot 5.2. Global Blood Screening Market by Technology, Performance - Potential Analysis 5.3. Global Blood Screening Market Estimates & Forecasts by Technology 2016-2026 (USD Billion) 5.4. Blood Screening Market, Sub Segment Analysis 5.4.1. Nucleic Acid Test (NAT) 5.4.2. Rapid Test 5.4.3. Western Blot Assay 5.4.4. Next-Generation Sequencing (NGS) Chapter 6. Global Blood Screening Market, by Product & Service 6.1. Market Snapshot 6.2. Global Blood Screening Market by Product & Service, Performance - Potential Analysis 6.3. Global Blood Screening Market Estimates & Forecasts by Product & Service, 2016-2026 (USD Billion) 6.4. Blood Screening Market, Sub Segment Analysis 6.4.1. Reagents & Kits 6.4.2. Instruments 6.4.3. Software & Service Chapter 7. Global Blood Screening Market, by End-Use 7.1. Market Snapshot 7.2. Global Blood Screening Market by End-Use, Performance - Potential Analysis 7.3. Global Blood Screening Market Estimates & Forecasts by End-Use, 2016-2026 (USD Billion) 7.4. Blood Screening Market, Sub Segment Analysis 7.4.1. Blood Bank 7.4.2. Hospital Chapter 8. Global Blood Screening Market, Regional Analysis 8.1. Blood Screening Market, Regional Market Snapshot 8.2. North America Blood Screening Market 8.2.1. U.S. Blood Screening Market 220.127.116.11. Technology breakdown estimates & forecasts, 2016-2026 18.104.22.168. Product & Service breakdown estimates & forecasts, 2016-2026 22.214.171.124. End-Use breakdown estimates & forecasts, 2016-2026 8.2.2. Canada Blood Screening Market 8.3. Europe Blood Screening Market Snapshot 8.3.1. U.K. Blood Screening Market 8.3.2. Germany Blood Screening Market 8.3.3. Rest of Europe Blood Screening Market 8.4. Asia-Pacific Blood Screening Market Snapshot 8.4.1. China Blood Screening Market 8.4.2. India Blood Screening Market 8.4.3. Japan Blood Screening Market 8.4.4. Rest of Asia Pacific Blood Screening Market 8.5. Latin America Blood Screening Market Snapshot 8.5.1. Brazil Blood Screening Market 8.5.2. Mexico Blood Screening Market 8.6. Rest of The World Blood Screening Market Chapter 9. Competitive Intelligence 9.1. Top Market Strategies 9.2. Company Profiles 9.2.1. Grifols 126.96.36.199. Overview 188.8.131.52. Financial (Subject to Data Availability) 184.108.40.206. Product Summary 220.127.116.11. Recent Developments 9.2.2. F. Hoffmann-La Roche 9.2.3. Abbott Laboratories 9.2.4. Biomerieux 9.2.5. Bio-Rad Laboratories, Inc. 9.2.6. Siemens Healthineers 9.2.7. Ortho Clinical Diagnostics, Inc. 9.2.8. Thermo Fisher Scientific, Inc. 9.2.9. Beckman Coulter 9.2.10. Becton, Dickinson & Company Chapter 10. Research Process 10.1. Research Process 10.1.1. Data Mining 10.1.2. Analysis 10.1.3. Market Estimation 10.1.4. Validation 10.1.5. Publishing 10.2. Research Attributes 10.3. Research Assumption
Global Blood Screening Market valued approximately USD 2.12 billion in 2018 is anticipated to grow with a healthy growth rate of more than 9.7% over the forecast period 2019-2026. Initiatives by the various organizations and governments increase awareness about donation and screening before transfusion. According to the WHO, approximately 108 million blood donations are collected every year across the globe. About 50% of these blood donations collected from high-income countries which is home to less than 20% of the total population. Hence, rising awareness coupled with the high demand for safe blood create opportunities in emerging countries. Growing numbers of blood donations and blood donors with growing consciousness about preserving donated blood and growing occurrence of transferable illnesses, growing call for donated blood, rise in spending on fitness, technical developments in blood screening, growing alertness for fitness and increasing number of initiatives by many administrations and government associations are a few important issues motivating the development of the global blood screening market size. Yet, composite controlling outlines for sanction, shortage of expert manpower, existence of another know-how like digital immunoassay associated with high original investment expenditure and operative costs of testing are the limiting issues for the development of the global blood screening market size.
The major manufacturers involved in this report are:
F. Hoffmann-La Roche
Bio-Rad Laboratories, Inc.
Ortho Clinical Diagnostics, Inc.
Thermo Fisher Scientific, Inc.
Becton, Dickinson & Company
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
Nucleic Acid Test (NAT)
Western Blot Assay
Next-Generation Sequencing (NGS)
By Product & Services:
Reagents & Kits
Software & Service
By End Use:
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Blood Screening Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers